Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology

ClinicalTrials.gov ID: NCT02702271

Public ClinicalTrials.gov record NCT02702271. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 4:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Protection Against Embolism for Non-valvular AF Subjects: Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study is a prospective, non-randomized, multi-center investigation to establish the safety and effectiveness of the WATCHMAN FLX™ Left Atrial Appendage Closure Device for subjects with non-valvular atrial fibrillation who are eligible for long-term anti-coagulation therapy to reduce the risk of stroke but who have a rationale to seek a non-pharmacologic alternative.

Study identification

NCT ID
NCT02702271
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Boston Scientific Corporation
Industry
Enrollment
458 participants

Conditions and interventions

Interventions

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 7, 2018 (Actual)
Primary completion
Jan 28, 2020 (Actual)
Completion
Mar 12, 2021 (Actual)
Last update posted
Jun 14, 2022

2018 – 2021

United States locations

U.S. sites
29
U.S. states
22
U.S. cities
27
Facility City State ZIP Site status
Grandview Medical Center Birmingham Alabama 35243 —
Phoenix Cardiovascular Research Group Phoenix Arizona 85006 —
St. Joseph's Hospital & Medical Center Phoenix Arizona 85016 —
Nair Research, LLC Jonesboro Arkansas 72401 —
Scripps Green La Jolla California 92037 —
Cedars-Sinai Medical Center Los Angeles California 90048 —
Sharpe Chula Vista Medical Center San Diego California 92121 —
St. John's Hospital / Pacific Heart Santa Monica California 90404 —
Washington Hospital Center Washington D.C. District of Columbia 20010 —
Tallahassee Memorial Hospital Tallahassee Florida 32308 —
Emory University Atlanta Georgia 30308 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Henry Ford Hospital Detroit Michigan 48202 —
Mayo Clinic Rochester Minnesota 55902 —
HealthEast St. Joseph's Hospital Saint Paul Minnesota 55102 —
Cardiology Associates of N. Mississippi Tupelo Mississippi 38801 —
St. Luke's Hospital Kansas City Missouri 64111 —
Catholic Medical Center Manchester New Hampshire 03102 —
Cardiovascular Associates of the Delaware Valley Sewell New Jersey 08080 —
New York University Medical Center New York New York 10016 —
Mt. Sinai School of Medicine New York New York 10029 —
Cleveland Clinic Cleveland Ohio 44195 —
Legacy Emanuel Hospital & Health Center Portland Oregon 97227 —
York Hospital York Pennsylvania 17403 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
Texas Cardiac Arrhythmia Austin Texas 78705 —
Sentara Norfolk General Hospital Norfolk Virginia 23507 —
Virginia Commonwealth University Health System Richmond Virginia 23219 —
PeaceHealth Southwest Medical Vancouver Washington 98664 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02702271, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 14, 2022 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02702271 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →